<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04779125</url>
  </required_header>
  <id_info>
    <org_study_id>115/2020</org_study_id>
    <nct_id>NCT04779125</nct_id>
  </id_info>
  <brief_title>APEMESH II - Perineal Reconstruction</brief_title>
  <official_title>Apemesh II - Perineal Reconstruction With Mesh Enhanced Gluteus Plasty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Oulu</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Oulu</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this pilot study is to assess the safety, functional outcome, feasibility&#xD;
      and the potential benefits of synthetic mesh strip and gluteus flap reconstruction in&#xD;
      perineum in case-control setting.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Several studies have reported over 30% morbidity with perineal wound healing after&#xD;
      abdominoperineal resection. Preoperative radiotherapy seems to be a strong predictor for&#xD;
      perineal complications. Musculocutaneus flaps and use of biological mesh seem to minimize&#xD;
      perineal morbidity.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 19, 2021</start_date>
  <completion_date type="Anticipated">April 30, 2023</completion_date>
  <primary_completion_date type="Anticipated">March 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>All patients, who have an abdominoperineal reconstruction for rectal cancer, will have a mesh enhanced gluteus plasty. The patients will be compared to historical cohort.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Complications</measure>
    <time_frame>30 days</time_frame>
    <description>Comprehensive complication index</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Surgical site infections</measure>
    <time_frame>30 days</time_frame>
    <description>Surgical site infections</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reoperation rate</measure>
    <time_frame>30 days</time_frame>
    <description>Reoperation rate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Operative time</measure>
    <time_frame>30 days</time_frame>
    <description>Operative time to reconstruct perineum</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of hospital stay</measure>
    <time_frame>30 days</time_frame>
    <description>Primary length of stay at the hospital</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Costs of treatment materials</measure>
    <time_frame>30 days</time_frame>
    <description>Costs of treatment materials</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total perineal healing time</measure>
    <time_frame>1 year</time_frame>
    <description>Time from operation to complete perineal healing</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Perineal fistula</measure>
    <time_frame>30 days</time_frame>
    <description>Perineal sinus or fistula</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Perineal hernia</measure>
    <time_frame>12 months</time_frame>
    <description>Perineal hernia incidence</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gluteus muscle function measured by time stands test</measure>
    <time_frame>12 months</time_frame>
    <description>Gluteus muscle function measured by time stands test</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Rectal Cancer</condition>
  <arm_group>
    <arm_group_label>Gluteus plasty enhanced with Progrip self gripping mesh</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All study patietns will have a gluteus enhanced plasty after abdominoperineal reconstruction.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Gluteus plasty enhanced with Progrip self gripping mesh</intervention_name>
    <description>Intervention group will be compared to historical patients in a case-control setting. Intervention group will have a mesh enhanced gluteus plasty made to reconstruct perineum after abdominoperineal resection.</description>
    <arm_group_label>Gluteus plasty enhanced with Progrip self gripping mesh</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Curative intent abdominoperineal resection and permanent colostomy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient with a comorbid illness or condition that would preclude the use of surgery&#xD;
             (ASA 4- 5)&#xD;
&#xD;
          -  Immunosupression (cortisone &gt;10mg/day) or severe malnutrition (BMI &lt;20)&#xD;
&#xD;
          -  Diabetes with 1 or more organ damage&#xD;
&#xD;
          -  Dialysis treatment&#xD;
&#xD;
          -  Hepatic cirrhosis Child-Bugh B-C&#xD;
&#xD;
          -  Potentially curable resection not possible&#xD;
&#xD;
          -  Patient undergoing emergency procedures&#xD;
&#xD;
          -  Metastatic disease&#xD;
&#xD;
          -  Vaginal resection, pelvic exenteration and sacrum resection&#xD;
&#xD;
          -  Vaginal perforation&#xD;
&#xD;
          -  Pelvic abscess or perforated tumor&#xD;
&#xD;
          -  Pregnant or suspected pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tero Rautio, M.D. Ph.D.</last_name>
    <role>Study Chair</role>
    <affiliation>Oulu University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Elisa Mäkäräinen-Uhlbäck, M.D.</last_name>
    <phone>+35883152282</phone>
    <email>elisa.makarainen-uhlback@ppshp.fi</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Katariina Kilpivaara, M.D.</last_name>
    <phone>+35883152011</phone>
    <email>katariina.kilpivaara@ppshp.fi</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Oulu University Hospital</name>
      <address>
        <city>Oulu</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elisa Mäkäräinen-Uhlbäck, M.D.</last_name>
      <phone>+35883152282</phone>
      <email>elisa.makarainen-uhlback@ppshp.fi</email>
    </contact>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>February 22, 2021</study_first_submitted>
  <study_first_submitted_qc>March 2, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 3, 2021</study_first_posted>
  <last_update_submitted>May 4, 2021</last_update_submitted>
  <last_update_submitted_qc>May 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Oulu</investigator_affiliation>
    <investigator_full_name>Elisa Makarainen-Uhlback</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>abdominoperineal resection</keyword>
  <keyword>perineal reconstruction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rectal Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

